# Jinyu Bio-technology

FMD and ASF vaccines — Cell-suspension culture.

Source: https://en.bioecon.ru/companies/jinyu-bio/
Updated: 2026-06-25

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | 1.255 billion yuan (2024-12-31) | https://file.finance.qq.com/finance/hs/pdf/2025/04/25/1223274656.PDF |
| Capacity | 2.7 billion mL of FMD vaccines annually | http://jinyubiotech.com/science/vaccines.html |
| Capacity | 2 billion doses of FMD vaccines annually | https://jinyubiotech.com/ |
| Production site | Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang production bases | https://file.finance.qq.com/finance/hs/pdf/2025/04/25/1223274643.PDF |
| Production site | Research facility in Kansas, USA | https://www.pharmaceutical-technology.com/projects/jinyu-bio-technology-research-facility-kansas/ |
| Certification | Veterinary GMP certification (2021) | https://static.sse.com.cn/stock/disclosure/announcement/c/202311/600201_20231114_CR20.pdf |
| Regulatory approval | 49 new veterinary drug registration certificates and 106 veterinary drug production approvals | https://static.sse.com.cn/stock/disclosure/announcement/c/202311/600201_20231114_CR20.pdf |
| Regulatory approval | Clinical trial approval for mRNA vaccine for feline infectious peritonitis (FIP) (2025-07-25) | https://news.futunn.com/en/post/59645909/major-breakthrough-in-treating-pet-incurable-diseases-first-domestic-mrna |
| Headquarters | Hohhot, Inner Mongolia, China | https://www.pharnexcloud.com/data/qynb_e798cf2d2cebb25b3ea51061bc003f14.html |

Independent sources: file.finance.qq.com, news.futunn.com, pharmaceutical-technology.com, pharnexcloud.com, static.sse.com.cn

## Technologies

- [Veterinary biotech & mRNA veterinary drugs](https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)